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Ultraviolet adiation is an important cause of melanoma,
so the use of sunscreen lotions has been advocated
for melanoma prevention. Several arguments have been
raised in opposition to this inference. Sunscreen use may
interfere with cutaneous vitamin D synthesis, which some
have hypothesized may lower melanoma risk. Sunscreen
users may compensate for their sunscreen use by staying
out much longer in the sun, or may use sunscreen lotions
inconsistantly. Published melanoma case-control studies
have not consistantly demonstrated a protective effect of
sunscreens; however, these studies do not provide strong
evidence, ultraviolet radiation is a known cause of
It is now well-established that ultraviolet radiation from the sunis a causal factor in the etiology of melanoma (InternationalAgency for Research on Cancer, 1992). This conclusion, andthe extensive body of evidence supporting it, have not beensubject to serious challenge. The use of sunscreen lotions to
prevent melanoma, however, although widely recommended, has been
the subject of some controversy (Angier, 1990; Garland et al, 1993;
Naylor et al, 1995; Weinstock, 1997; Gasparro et al, 1998).
VITAMIN D
Concern has been expressed that vitamin D may inhibit melanoma
formation, and that sunscreen use may lead to decreased levels of
vitamin D, and therefore to greater risk of melanoma (Angier, 1990;
Garland et al, 1993). The human body obtains vitamin D from two
major sources: synthesis in the skin using ambient ultraviolet radiation
and ingestion in the diet. If ultraviolet-induced vitamin D inhibits
melanoma, so should the chemically identical diet-derived vitamin D.
Indeed, dietary vitamin D assessed by questionnaire has been correlated
with vitamin D stores even in summer months (Sowers et al, 1986).
Hence a case-control study was performed to evaluate the association
of dietary vitamin D with melanoma risk (Weinstock et al, 1992).
The study population included Caucasian adult outpatients who had
no personal history of noncutaneous malignancy, no medical diagnosis
that could affect nutritional status, and no history of metastatic skin
cancer. Cases included 165 melanoma patients, and controls included
209 patients with neither melanoma nor dysplastic nevi. Dietary intake
was assessed by a previously validated food frequency questionnaire,
and adjusted for total energy intake (Willett et al, 1985; Stryker
et al, 1990). The mean adjusted vitamin D intake (6SE), including
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melanoma, and ultraviolet B may be particularly potent,
so on balance the evidence supports continued advocacy
of sunscreen lotion use as part of an overall sun-protection
regimen. Uncertainty will remain, however, until the
action spectrum of melanoma is convincingly demon-
strated or the methodologic limitations of existing epide-
miologic evidence are overcome. The latter may require
another decade or more of experience with sunscreen
use. Key words: case-control studies/epidemiology/melanoma/
sunscreen. Journal of Investigative Dermatology Symposium
Proceedings 4:97–100, 1999
supplements, in cases and controls was 347 6 25 IU and 309 6 19 IU,
respectively (p 5 0.2). Similarly, there were no significant differences
if supplements were excluded, and supplements themselves were
associated with an odds ratio of 1.3 (95% confidence interval 0.8–2.2,
p 5 0.3), where an odds ratio significantly less than 1.0 would have
suggested that melanoma risk is associated with decreased vitamin D
intake. Furthermore, the leading source of vitamin D from food, i.e.
milk consumption, was also not associated with melanoma risk in this
study. The relation of melanoma risk to vitamin D ingestion by quintile
of total dietary vitamin D intake is displayed in Table I. No significant
trend was noted. These data suggest that vitamin D intake is unrelated to
melanoma risk. To the author’s knowledge, no substantial contradictory
evidence has been published (Weinstock et al, 1992).
Other arguments have also been forwarded against the vitamin D–
melanoma link, including the tight metabolic regulation of levels of
the active form of vitamin D in patients who are not frankly vitamin
D deficient. Also, clinical trials of sunscreen use have not produced
abnormally low vitamin D levels, and extraordinarily photoprotected
populations have been noted to have normal vitamin D levels (Marks
et al, 1995; Sollitto et al, 1997).
ACTION SPECTRUM
The action spectrum for erythema in humans has been determined
(McKinlay and Diffey, 1987). The Sun Protection Factor (SPF) number
on the label of sunscreen lotions is based on the erythema reaction in
humans, and many of the sunscreen products sold are very effective in
preventing erythema, as indicated by an SPF number of 15 or greater.
Unfortunately, the animal models available for melanoma are quite
limited, and the action spectrum for melanoma itself is unknown. The
rare genetic disorder xeroderma pigmentosum may serve as a model
for melanoma in the general population (Weinstock, 1992). Individuals
with this disorder have an inherited defect in the repair of UVB-
induced pyrimidine dimers in their DNA, which is associated with a
markedly increased susceptibility to sunburn and a several thousand-
fold greater risk of melanoma than the general population, despite a
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Table I. Relation of vitamin D intake to melanoma risk
(Weinstock et al, 1992)
Quintile of vitamin D intakea Relative risk 95% confidence interval
,105 IU 1.0 reference group
106–188 IU 1.0 0.5–2.1
189–266 IU 0.7 0.3–1.5
267–394 IU 1.3 0.6–2.6
.395 IU 1.8 0.9–3.5
aCalorie-adjusted daily intake, controlled for age, hair color, and family history of
melanoma.
similar distribution of melanomas on the body surface (Kraemer et al,
1994). This observation is consistant with the hypothesis that the action
spectrum for melanoma is similar to the erythema action spectrum.
Nevertheless, additional models are needed before inferences can be
drawn with confidence. Present evidence is insufficient to exclude the
possibility that the melanoma action spectrum is more heavily weighted
in the UVA region than the erythema action spectrum. This possibility
gives rise to another possible mechanism by which melanoma risk
could be augmented by sunscreen use.
THE COMPENSATION HYPOTHESIS
The compensation hypothesis posits the following: (i) sunscreens are
more effective at blocking the erythema action spectrum than the
melanoma action spectrum; (ii) people who use sunscreen use it
primarily to avoid sunburn; (iii) hence people will increase their sun
exposure substantially due to application of sunscreen lotions, to the
point at which they get their usual degree of sunburn; (iv) sunscreen
users will thereby actually expose themselves to more solar radiation
in the wavelengths responsible for melanoma induction, and hence
develop more melanomas.
Premise (i) depends on there being a substantial difference between
the action spectra for erythema and the one for melanoma, which has
certainly not been demonstrated. Even if it is true, the compensation
hypothesis depends on the difference being of substantial enough
magnitude to overcome the protection afforded by sunscreens against
the melanomagenic wavelengths of solar radiation. Proponents of this
premise typically argue that UVA is primarily responsible for melanoma,
whereas UVB is primarily responsible for sunburn. It is true that most
sunscreen lotions are relatively more effective at blocking UVB than
UVA, although some increasingly popular components of sunscreens,
e.g. titanium dioxide and zinc oxide, block well into the UVA range.
Premise (ii), that sunscreens are used primarily to avoid sunburn, is
certainly not true for some, and is likely untrue for a substantial
segment of the population, although good population-based data are
lacking. One study of 200 randomly selected 13–14-y-old adolescents
in Marseille in 1989 found that 15% used sunscreens to prevent long-
term complications, 60% to avoid sunburns, but only 6% to allow
greater sun exposure (Grob et al, 1993). Those who use sunscreen for
melanoma prevention are, by definition, not using them primarily for
sunburn avoidance, so if public health campaigns for cancer prevention
are at all effective in persuading the population to use sunscreens, they
are likely to be effective in persuading them to use them for reasons
other than sunburn avoidance. Conclusion (iii), that sunscreen users
compensate for the sunscreen use by staying in the sun longer to
achieve their usual degree of sunburn, is therefore questionable. In our
own surveys of beachgoers in south-eastern New England, there was
a positive correlation between the use of sunscreen and the use of
other sun protection techniques, such as wearing a shirt and limiting
time in the sun (Weinstock and Rossi, 1998; Weinstock et al, 1998).
Furthermore, in many situations, one simply cannot achieve a sunburn
while wearing sunscreen. For example, a New Englander who may
develop a painful sunburn after an hour on the beach at noon in the
summer without sunscreen would find it impossible to burn with a
proper application of an SPF 15 sunscreen, because there is simply not
enough ultraviolet radiation reaching New England beaches between
dawn and dusk, even in the summer. In temperate climates where
much of the population lives, sunscreen users cannot fully compensate
(i.e. to the point of burning). The limited degree of compensation
that is possible for many limits more severely the possibility of increasing
exposure to wavelengths of radiation potentially more effective in
melanoma induction. Hence the conclusion (iv) of the compensation
hypothesis is likely to be incorrect, and is particularly likely to be
incorrect for much of the U.S.A. population that lives in areas (such
as New England) with modest ultraviolet flux.
INCONSISTENT USE
Melanoma risk has been linked with intense intermittent exposure to
solar radiation (Elwood, 1992; Elwood and Jopson, 1997). Sunscreens
could therefore theoretically increase melanoma risk if they led to
increased intermittency of ultraviolet radiation exposure. Of course,
intermittent use is not recommended by manufacturers or public health
campaigns; indeed, quite the contrary. Nevertheless, some individuals
may use sunscreens irregularly when exposed to intense solar ultraviolet.
If these individuals were already exposing themselves intermittently
to solar radiation, inconsistent sunscreen use would not affect the
‘‘intermittentcy’’ of their exposure, but would reduce the magnitude
of their exposure. On the other hand, if these people were constantly
exposed to intense sunlight, and used sunscreens inconsistently, that
would result in a more intermittent exposure pattern and hence,
possibly greater melanoma risk. Furthermore, even people who apply
sunscreen lotions consistently when in intense solar radiation may
occasionally miss a spot, which then becomes an intermittently
exposed location.
CASE-CONTROL STUDIES
To date 12 epidemiologic studies of the relation of sunscreen use to
melanoma risk have been published, and one additional unpublished
study is known to this author (Berwick et al unpublished data). In
three of these, sunscreen use was associated with decreased melanoma
risk (although assessment of statistical significance was unavailable for
one), in four, with increased risk, and in six no clear association
was demonstrated (see Table II). The apparently descrepant results
underscore the importance of several methodologic issues.
The first group of issues relate to the characterization of the sunscreen
lotions used. These studies usually failed to distinguish between lotions
with low SPF values and those with high SPF values (the exceptions
are listed in Table II), whether the general term used in the questions
referred to ‘‘sun lotions’’, ‘‘sunscreens’, or ‘‘suntan lotions’’. None of
these studies reported their data within strata of SPF (although one
shared this unpublished data; Green et al, 1986), so we generally do
not know the proportion of users who applied SPF 2 lotions and the
proportion who applied lotions with SPF greater than 15. The SPF
number may not have been printed on the bottle label during the
years that some of these study participants were using these lotions.
In Europe, but not in the U.S.A., some sunscreen lotions contain
5-methoxypsoralen (5-MOP). This is a close relative of 8-methoxy-
psoralen, which has been linked to melanoma induction in human
psoriasis patients in a recent study (Stern et al, 1997). Hence it becomes
critical to determine whether the lotions used by study participants
contained this ingredient. Only one study (Autier et al, 1995) separated
these two types of lotions in their analysis.
The initiation, duration, frequency, circumstances, and consistency
of sunscreen use are particularly important in evaluating a potential
link to melanoma risk. Crude assessment of frequency of application,
and in some cases duration of use, were included in many of the
studies, but the level of detail was, in general, quite limited.
Exposure assessment is also complicated by the limitations of
retrospective recall, and by the possibility of recall bias, which has been
demonstrated for some melanoma risk factors (Weinstock et al, 1991).
The second group of issues pertains to the analysis of results.
Although some of the reports did describe detailed analyses, most did
not because these analyses were not central to their manuscripts. Of
particular interest is the dose–response relation with consistancy of use,
duration of use, time since initiation of use, SPF of the lotions used,
and frequency of use. Adjustment for a presumed lag time between
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Table II. Case-control studies of the association of sunscreen use and melanoma risk
Study Relative risk (95% CI) Year Location Control varsa Reference
United States
Graham 2.2 (1.2–4.1) men 1974–80 New York State none (Graham et al, 1985)
1.7 (1.1–2.7) men (suntan lotions)
ns women
Herzfeld ns 1977–79 New York State ss, se (Herzfeld et al, 1993)
Berwick 1.1 (0.8–1.5) sometimes 1987–89 Connecticut ss, se (unpublished data 1998)
1.3 (0.9–1.6) almost always
Holly 0.7 (0.5–0.9) sometimes 1981–86 California ss, sunburns (Holly et al, 1995)
0.5 (0.3–0.7) never
Australia
Green 0.8 always when in sun 1979–80 Queensland ss (Green et al, 1986)
and (unpublished data 1998)
(0.6 high SPF, 0.8 low SPF, 2.5 tanning oils)
Holman 1.1 (0.7–1.6) , 10 y use 1980–82 Western Australia ss (Holman et al, 1986)
1.2 (0.8–1.7) . 10 y use
1.1 (0.7–1.7) , 12 time
1.1 (0.8–1.6) . 12 time
Whiteman Use on holiday (versus never/rarely) 1987–94 Queenslandb ss, freckling (Whiteman et al, 1997)
1.5 (0.3–8.2) sometimes
1.5 (0.3–7.4) often
2.2 (0.4–11.6) always
Use at school (versus never/rarely)
0.8 (0.3–2.1) sometimes
1.6 (0.5–5.5) often
0.7 (0.1–6.0) always
Europe
Klepp 1974–75 Norway none (Klepp and Magnus, 1979)
1.8 (1.2–2.7) sometimes/quite often
3.1 (1.4–7.1) almost always
Beitner 1.6 (1.1–2.3) seldom 1978–83 Sweden ss (Beitner et al, 1990)
1.7 (1.0–2.9) often/very often
Osterlind 1.3 (1.0–1.6) occasionally 1982–85 Denmark none (Osterlind et al, 1988)
1.1 (0.8–1.5) always
1.3 (0.9–1.7) , 10 y
1.2 (0.9–1.5) 101 y
Westerdahl 1.3 (0.9–1.9) sometimes 1988–90 Sweden ss, se (Westerdahl et al, 1995)
1.8 (1.1–2.8) almost always
Rodenas 0.6 (0.3–1.4) sometimes 1989–93 Spain ss,se (Ro´denas et al, 1996)
0.2 (0.0–0.8) always
Autier 1.5 (1.1–2.1) without 5-MOP 1991–92 Germany, ss, se (Autier et al, 1995)
2.3 (1.3–4.0) with 5-MOP France, Belgium
1.3 (0.8–2.1) self-tanning cosmetics
aReport included analyses controlled for an indicator of sun sensitivity (ss) or sun exposure (se) if indicated. Some reports included analyses controlled for other variables as well (e.g., gender).
None included control for socioeconomic status.
bAll cases age 0–14 y.
exposure to ultraviolet radiation and diagnosis of melanoma also would
be useful.
Confounding is a particular concern in this group of studies. In
particular, sun sensitivity, sun exposure, and socioeconomic status are
all likely to be confounding variables, because each of these are
associated with both sunscreen use and melanoma risk. Manifestations
of sun damage may also lead to sunscreen use. As indicated in Table II,
some of these variables were controlled in many of the reports. Any
one of them could produce a spurious association between sunscreen
use and melanoma risk, and indeed, two of the reports (Holman et al,
1986; Herzfeld et al, 1993) noted that crude associations disappeared
after adjustment. It should be noted that appropriate adjustment for
these variables, particularly sun exposure, is quite difficult because sun
exposure in particular is a difficult variable to measure accurately with
retrospective recall. Hence even after adjusting for confounders, the
possibility of residual confounding must be considered.
Publication bias is an important concern in evaluating the sunscreen-
melanoma link because negative findings may be viewed as unattractive
to journal editors and hence be less likely to be submitted for publication
and less likely to be published. In addition, negative findings have in
general been presented in much less detail when published. Similarly,
observations that sunscreens protect against melanoma may be de-
emphasized because that is the conventional expectation, and observ-
ations that sunscreens are risk factors for melanoma may be withheld
because they are presumed artifacts of methodologic defects, such as
those discussed herein.
Finally, statistical power is an absolutely critical issue. Sunscreening
lotions with SPF . 5 did not exceed lotions with SPF , 5 in sales in
the U.S.A. until 1987. Hence most of the pre-1987 use of sunscreens
was of relatively ineffective products whose use is not currently
recommended. The power of an epidemiologic study to document a
melanoma preventive effect is therefore severely compromised.
Melanoma is also characterized by a significant lag time between
ultraviolet exposure and diagnosis of the malignancy. Hence it may be
that use within the immediately prior 15 y bears no relation to
melanoma risk even if sunscreens are remarkably effective in reducing
risk over the longer term or when used in childhood and in the young
adult years. Failure to take the lag period into account is a weakness
in the analysis of many of these studies. The requirement for effective
lotions to have been used many years prior to the study is a severe
limitation on a study’s power to detect an association that may
be present.
THE CASE OF SQUAMOUS CELL CARCINOMA (SCC) OF
THE SKIN
In light of these limitations, the association between sunscreen use and
SCC bears scrutiny. The epidemiologic and clinical features of SCC
100 WEINSTOCK JID SYMPOSIUM PROCEEDINGS
have left little doubt that sun exposure is a key cause of this malignancy.
Furthermore, unlike melanoma, we have well-described mammalian
models of ultraviolet radiation-induced SCC, and the action spectrum
has been documented (de Gruijl et al, 1993; de Gruijl and van der Leun,
1994). This action spectrum is very similar to the erythema action
spectrum in humans. Without a substantial difference between sunburn
and SCC in action spectra, the compensation hypothesis cannot hold.
Furthermore, intermittent patterns of exposure have not been linked
to SCC risk, so inconsistant use of sunscreens is unlikely to be harmful
for that reason. Sunscreens therefore should be effective in preventing
SCC. Support for this inference is provided by two published random-
ized controlled trials that indicate that sunscreens are effective in the
treatment and prevention of actinic keratoses, a documented precursor
of SCC (Thompson et al, 1993; Naylor et al, 1995).
Two published observational studies have evaluated the link between
SCC and sunscreen use. Both are cohort studies, so are free from some
of the potential limitations of exposure measurement mentioned above,
such as recall bias. The first of these found no significant association
between SCC and sunscreen use (OR 0.9; 95% CI 0.6–1.2) (Grodstein
et al, 1995). The second focussed primarily on actinic keratoses, and
found no association between sunscreen use and either occurance of
new actinic keratoses or regression of existing actinic keratoses (Harvey
et al, 1996). Each study has its own limitations, but together they
illustrate the difficulty of using current approaches for assessment of
the impact of sunscreen use on the subsequent occurance of cutaneous
malignancy.
CONCLUSIONS
Existing epidemiologic studies of the association of sunscreen use and
melanoma risk are inadequate to determine the magnitude and direction
of that association. A randomized trial of sunscreen use for the
prevention of melanoma is not feasible because of the long lag period
of melanoma, and because the incidence of melanoma, even in
Queensland, Australia, which has the highest reported incidence, is
only one per 3000 per year, so trial size and duration would be
prohibitive. Also, performing random allocation while holding other
sun protection measures constant is particularly difficult in a high
incidence environment. Randomized trials of sunscreen use for
surrogate endpoints (e.g., nevi) are possible and are underway.
Regrettably, it may be necessary to wait for another decade or two
for adequate numbers of people to have been using high SPF broad
spectrum sunscreens for long enough to have the power to evaluate
the effectiveness of these lotions in epidemiologic studies of melanoma
prevention. In the meanwhile, the use of sunscreens is justified by
indirect evidence, including the known role of ultraviolet exposure in
the genesis of melanomas, the likelihood that ultraviolet B is an
important mediator of this process, and the direct evidence of the
efficacy of sunscreens in the prevention of other forms of actinic
neoplasia. As broader spectrum sunscreens become more widely used,
the case for sunscreen use becomes more compelling, particularly when
these lotions are used consistantly and for prevention of cancer (i.e.,
not for the purpose of prolonging sun exposure). The available evidence
does not indicate a need to alter existing public health messages that
encourage use of sunscreens, clothing, and sun avoidance for melanoma
prevention.
Note: After acceptance of this paper, presentation of a randomized
trial of sunscreen use among children suggested that sunscreen
lotion is effective in preventing the formation of nevi (JK Rivers,
March 1999).
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